Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Overview of attention for article published in BMJ Open Diabetes Research & Care, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 1,006)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 9 news outlets
blogs: 1 blog

twitter: 30 tweeters

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 32 Mendeley

Summary News Blogs Twitter Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Metabolic and Bariatric Endoscopy: A Mini-Review

Article in Life (September 2023)

Combining Celiac and Hepatic Vagus Nerve Neuromodulation Reverses Glucose Intolerance and Improves Glycemic Control in Pre- and Overt-Type 2 Diabetes Mellitus

Article in Biomedicines (September 2023)

Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?

Article in Diabetes/Metabolism Research and Reviews (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.